Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Hisakazu Nishimori, MD, Haruko Sugiyama, MD, Koichiro Kobayashi, MD, Yoshiko Yamasuji, MD, Eisei Kondo, MD, PhD, Katsuji Shinagawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kengo Takeuchi, MD, PhD, Yoshinobu Maeda, MD, PhD

Blood (2009) 114 (22): 4487.

https://doi.org/10.1182/blood.V114.22.4487.4487

Published: 2009

Journal Articles

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Koichiro Kobayashi, MD, Yoshinobu Maeda, MD, Hisakazu Nishimori, MD, Haruko Sugiyama, MD, Kazutoshi Aoyama, MD, Tomoko Kikuchi, MD, Noriko Namba, MD, Shiro Kubonishi, MD, Masami Niiya, MD, Katsuji Shinagawa, MD, Kazuma Ikeda, MD, Mitsune Tanimoto, MD

Blood (2008) 112 (11): 1967.

https://doi.org/10.1182/blood.V112.11.1967.1967

Published: 2008

Journal Articles

Cyclosporine, but Not mTOR Inhibitors, Hampers the Reconstitution of Bone Marrow-Derived Tregs in Long-Term Complete Donor chimeras .

Haruko Sugiyama, MD, Yoshinobu Maeda, MD, Hisakazu Nishimori, MD, Koichiro Kobayashi, MD, Miyuki Nishie-Kataoka, MD, Takanori Teshima, MD, Mitsune Tanimoto, MD

Blood (2008) 112 (11): 2331.

https://doi.org/10.1182/blood.V112.11.2331.2331

Published: 2008

Journal Articles

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Koichiro Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Mitsune Tanimoto, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2006) 108 (11): 2902.

https://doi.org/10.1182/blood.V108.11.2902.2902

Published: 2006

Journal Articles

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Koichiro Kobayashi, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2006) 108 (11): 2709.

https://doi.org/10.1182/blood.V108.11.2709.2709

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Cyclosporine, but Not mTOR Inhibitors, Hampers the Reconstitution of Bone Marrow-Derived Tregs in Long-Term Complete Donor chimeras .

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Email alerts

ASH Publications

American Society of Hematology

Update search

Synthetic Retinoid Am80 Ameliorates Chronic Graft-Versus-Host Disease.

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Cyclosporine, but Not mTOR Inhibitors, Hampers the Reconstitution of Bone Marrow-Derived Tregs in Long-Term Complete Donor chimeras .

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only